Ranibizumab
ATC S01LA04 · 11 markets · 86 records
AU 17 records · 7 strengths
- 10 mginjectionSUSVIMO ranibizumab 100 mg/mL solution for injection vial for use with the Contivue ocular implant
- 2.3 mg/0.23 mLinjectionLUCENTIS
- 2.3 mginjectionBYOOVIZ ranibizumab 10 mg/mL solution for injection vialLUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL solution for injection viall、SIMULARA ranibizumab (rbe)2.3mg/0.23mL solution for injection vial、SOLENTIS ranibizumab (rbe)2.3mg/0.23mL solution for injection vial、ZIVRA ranibizumab (rbe)2.3mg/0.23mL solution for injection vial
- 1.65 mginjectionLUCENTIS ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringeRANIVIZ ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection pre-filled syringe、SIMULARA ranibizumab (rbe) 1.65mg/0.165 mL solution for injection pre-filled syringe、SOLENTIS ranibizumab (rbe) 1.65mg/0.165 mL solution for injection pre-filled syringe、VURJOR ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringe、ZIVRA ranibizumab (rbe) 1.65mg/0.165 mL solution for injection pre-filled syringe
- 1.65 mg/0.165 mLinjectionLUCENTIS
- 10 mg/mLinjectionRANIVIZ ranibizumab (rbe) 10 mg/mL solution for injection vial
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 11 records · 5 strengths
EU 10 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
10 records · 0 manufacturers 10 registros · 0 fabricantes 10 个记录 · 0 个厂家 10 個記錄 · 0 個廠商
and 2 more (0 manufacturers) y 2 más (0 fabricantes) 还有 2 个(0 个厂家) 還有 2 個(0 個廠商)
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 9 records · 4 strengths
- 2.3 mg/0.23 mLinjectionByooviz 2.3mg/0.23ml solution for injection vialsLucentis 3mg/0.3ml solution for injection vials、Ongavia 2.3mg/0.23ml solution for injection vials、Ranivisio 2.3mg/0.23ml solution for injection vials、Rimmyrah 2.3mg/0.23ml solution for injection vials、Ximluci 2.3mg/0.23ml solution for injection vials
- 1.65 mg/0.165 mLinjectionLucentis 1.65mg/0.165ml solution for injection pre-filled syringes
- 3 mg/0.3 mLinjectionLucentis 3mg/0.3ml solution for injection vials
1 records · 1 manufacturers 1 registros · 1 fabricantes 1 个记录 · 1 个厂家 1 個記錄 · 1 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 7 records · 2 strengths
ES 7 records · 1 strengths
- 10 mg/1 mLinjectionBYOOVIZ PRECARGADALUCENTIS、LUCENTIS PRECARGADA、RANIVISIO、RIMMYRAH、XIMLUCI
FR 5 records · 1 strengths
- 10 mg/1 mLinjectionLUCENTIS 10 mg/ml, solution injectable en seringue préremplieRANIVISIO 10 mg/mL, solution injectable、RANIVISIO 10 mg/mL, solution injectable en seringue préremplie、RIMMYRAH 10 mg/ml, solution injectable、XIMLUCI 10 mg/mL, solution injectable
TW 3 records · 2 strengths
- 10 mginjectionLucentis 10mg/ml solution forLucentis solution for injection 10mg/mL in pre-filled syringe、樂舒晴注射劑 10 毫克/毫升、樂舒晴注射劑 10毫克/毫升 (預充填注射針筒)
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 3 records · 1 strengths
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 2 records · 2 strengths
- 2.3 mginjectionLucentis 10mg/ml solution for
- 1.65 mg/0.165 mLinjectionLUCENTIS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 1.65mg/0.165ml
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 mg/1 mL injection | BYOOVIZ PRECARGADA LUCENTIS LUCENTIS PRECARGADA | LUCENTIS 10 mg/ml, solution injectable en seringue préremplie RANIVISIO 10 mg/mL, solution injectable RANIVISIO 10 mg/mL, solution injectable en seringue préremplie+2RIMMYRAH 10 mg/ml, solution injectable XIMLUCI 10 mg/mL, solution injectable | |||||||||
| 10 mg injection | Byooviz LUCENTIS | SUSVIMO ranibizumab 100 mg/mL solution for injection vial for use with the Contivue ocular implant | Lucentis 10mg/ml solution for Lucentis solution for injection 10mg/mL in pre-filled syringe 樂舒晴注射劑 10 毫克/毫升 | ||||||||
| 2.3 mg/0.23 mL injection | Byooviz 2.3mg/0.23ml solution for injection vials Lucentis 3mg/0.3ml solution for injection vials Ongavia 2.3mg/0.23ml solution for injection vials+3Ranivisio 2.3mg/0.23ml solution for injection vials Rimmyrah 2.3mg/0.23ml solution for injection vials Ximluci 2.3mg/0.23ml solution for injection vials | LUCENTIS | |||||||||
| 2.3 mg injection | BYOOVIZ ranibizumab 10 mg/mL solution for injection vial LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL solution for injection viall SIMULARA ranibizumab (rbe)2.3mg/0.23mL solution for injection vial+2SOLENTIS ranibizumab (rbe)2.3mg/0.23mL solution for injection vial ZIVRA ranibizumab (rbe)2.3mg/0.23mL solution for injection vial | Lucentis 10mg/ml solution for | |||||||||
| 1.65 mg injection | LUCENTIS ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringe RANIVIZ ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection pre-filled syringe SIMULARA ranibizumab (rbe) 1.65mg/0.165 mL solution for injection pre-filled syringe+3SOLENTIS ranibizumab (rbe) 1.65mg/0.165 mL solution for injection pre-filled syringe VURJOR ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringe ZIVRA ranibizumab (rbe) 1.65mg/0.165 mL solution for injection pre-filled syringe | ||||||||||
| 10 mg liquid | LUCENTIS MELVIZO RANOPTO+1RANVU | ||||||||||
| 1.65 mg/0.165 mL injection | Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes | LUCENTIS | LUCENTIS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 1.65mg/0.165ml | ||||||||
| 0.5 mg/0.05 mL injection | CIMERLI NUFYMCO | ||||||||||
| 0.3 mg/0.05 mL injection | CIMERLI NUFYMCO | ||||||||||
| 100 mg liquid | Susvimo | ||||||||||
| 100 mg injection | Susvimo | ||||||||||
| 10 mg/mL injection | RANIVIZ ranibizumab (rbe) 10 mg/mL solution for injection vial | ||||||||||
| 6 mg injection | LUCENTIS | ||||||||||
| 3 mg/0.3 mL injection | Lucentis 3mg/0.3ml solution for injection vials | ||||||||||
unknown | LUCENTIS Susvimo | LUCENTIS SOLUTION FOR INJECTION 2.3MG/0.23ML (VIAL+FILTER NEEDLE PACK) LUCENTIS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 10MG/ML | Byooviz Epruvy LUCENTIS | ||||||||
injection | Manufacturer: Special Order | SUSVIMO Solution for 舒適眸注射劑 | |||||||||
liquid | RANIVISIO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · ES · MX · FR and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · ES · MX · FR que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · ES · MX · FR 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 CA · ES · MX · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.